Hazlett, Burt & Watson’s Chemours CC Stock Holding History

Hazlett, Burt & Watson’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6K	Sell	300 -100	-25%	-$2.29K	﹤0.01%	747
2026 Q1	$9K	Hold	400	–	–	﹤0.01%	703
2025 Q4	$5K	Buy	+400	New	+$5.14K	﹤0.01%	778
2025 Q3	–	Sell	-80	Closed	-$1K	–	873
2025 Q2	$1K	Hold	80	–	–	﹤0.01%	753
2025 Q1	$1K	Hold	80	–	–	﹤0.01%	755
2024 Q4	$1K	Hold	80	–	–	﹤0.01%	726
2024 Q3	$2K	Hold	80	–	–	﹤0.01%	671
2024 Q2	$2K	Buy	80 +1	+1%	+$26	﹤0.01%	649
2024 Q1	$2K	Hold	79	–	–	﹤0.01%	639
2023 Q4	$2K	Buy	79 +1	+1%	+$27	﹤0.01%	611
2023 Q3	$2K	Buy	78 +1	+1%	+$34	﹤0.01%	631
2023 Q2	$3K	Hold	77	–	–	﹤0.01%	588
2023 Q1	$2K	Buy	77 +1	+1%	+$33	﹤0.01%	563
2022 Q4	$2K	Buy	+76	New	+$2.28K	﹤0.01%	570

Other funds holding CC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCPM

Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Hazlett, Burt & Watson's CC Position: Q2 2026 in Review

Hazlett, Burt & Watson reduced its Chemours (CC) stake by 25% in Q2 2026, selling an estimated $2.29K and leaving 300 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #747.

Hazlett, Burt & Watson first reported a position in CC in Q4 2022 and has held it in 14 quarters since. The position peaked at $9K in Q1 2026. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

Hazlett, Burt & Watson held 300 shares of Chemours worth $6K as of Q2 2026.
Hazlett, Burt & Watson sold 100 Chemours shares in Q2 2026, an estimated $2.29K.
Chemours made up ﹤0.01% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #747 holding.
Hazlett, Burt & Watson first reported a position in Chemours in Q4 2022 and has held it in 14 quarters since.
Hazlett, Burt & Watson's Chemours position peaked at $9K in Q1 2026.
469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.